TPP Cosmetics Annex Is 'Signal To The World' For Regulatory Best Practices

Recently released text from the Trans-Pacific Partnership outlining cosmetics regulatory best practices promises to be a "signal to the world," according to the Personal Care Products Council. The cosmetics annex calls for a risk-based approach to safety assessment and oversight systems based on postmarket surveillance rather than premarket authorization, among other principles that TPP parties would be expected to embrace if the deal goes through.

The Trans-Pacific Partnership's dedicated cosmetics component would promote oversight systems across member countries based on risk-based safety evaluations and postmarket surveillance versus premarket authorization – in short, frameworks similar to that in place in the US.

Francine Lamoriello, executive VP of global affairs at the Personal Care Products Council, says the instrument, if ratified, will send...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight

People On The Move: Appointments At AESGP, PGEU, Nicapur

 
• By 

A round-up of the latest European health & wellness appointments: Workman re-elected AESGP chair; PGEU names 2026 leadership; Nicapur gets managing director.

Innovations In US Hemp Market, Like States’ Regulatory Interest, More Than Skin Deep

 

Market growth and product innovations are continuing as FDA looks to Congress for authorization to establish regulatory pathway agency says it needs to determine whether to allow hemp-derived ingredients in food, dietary supplements and non-drug topicals including cosmetics.

House Bill Aims to ‘Modernize’ US FDA’s Review Process For Sunscreens

 

Four co-chairs of the House of Representatives’ Skin Cancer Caucus have introduced the Safe Sunscreen Standards Act to direct FDA to establish clearer, ‘more flexible’ standards for evaluating sunscreen ingredients.